This inventor holds 8 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignees: King's College London, Caldan Therapeutics Limited. Active years: 2016-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2023
Title: Jane Theresa Brown – Innovator in Therapeutic Compounds
Introduction
Jane Theresa Brown, an accomplished inventor based in Nottingham, GB, has made significant contributions to the field of therapeutic compounds. With a total of 8 patents to her name, her work is characterized by innovation and a focus on addressing critical health challenges through novel compounds.
Latest Patents
Among her latest patents is the invention concerning crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid, referred to as 'BHBA-001'. This invention specifically targets the activation of the retinoic acid receptor beta (RARβ), particularly RARβ2, with applications aimed at promoting neurite development and regeneration, particularly crucial in treating neurological injuries such as spinal cord injuries. Another notable patent involves bicycloheteroaryl-heteroaryl-benzoic acid compounds which serve a similar function as RARβ agonists, enhancing therapeutic options for various conditions mediated by this receptor.
Career Highlights
Jane Theresa Brown's career is marked by her tenure at renowned institutions, including King's College London and Caldan Therapeutics Limited. Her role in these organizations has significantly influenced her research and development process, facilitating the advancement of her innovative ideas into practical applications.
Collaborations
Throughout her career, Jane has collaborated with esteemed colleagues, notably Alan D Borthwick and Jonathan Patrick Thomas Corcoran. These partnerships have enriched her innovative endeavors, enabling a diverse exchange of ideas and enhanced research output in the realm of therapeutic applications.
Conclusion
In conclusion, Jane Theresa Brown stands out as a pivotal figure in the field of therapeutic compounds, with a dedicated focus on innovations that can potentially improve the lives of those affected by neurological conditions. Her contributions through patents and collaborative efforts reflect her commitment to advancing medical science and providing solutions through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile